Advertisement

Annals of Surgical Oncology

, Volume 26, Issue 10, pp 3032–3039 | Cite as

Breastfeeding and Breast Cancer: Managing Lactation in Survivors and Women with a New Diagnosis

  • Helen M. Johnson
  • Katrina B. MitchellEmail author
Breast Oncology

Abstract

Background

Supporting breastfeeding is a global health priority, yet few clinical guidelines exist to guide surgical oncologists in managing lactation during or after breast cancer treatment.

Methods

The literature was reviewed to identify evidence-based strategies for managing lactation during multidisciplinary breast cancer treatment or among breast cancer survivors.

Results

The majority of the evidence is from observational studies, with some higher levels of evidence, including systematic reviews and meta-analyses. Several significant gaps in knowledge remain.

Conclusions

This review serves as a comprehensive resource of evidence-based recommendations for managing lactation in breast cancer survivors and breastfeeding women with a new breast cancer diagnosis.

Notes

Acknowledgment

Dr. Mitchell acknowledges her patients for consenting to share their clinical and radiographic images.

Disclosure

Helen M. Johnson and Katrina B. Mitchell have nothing to disclose.

References

  1. 1.
    Stuebe A. The risks of not breastfeeding for mothers and infants. Rev Obstet Gynecol. 2009;2(4):222–31.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002;360(9328):187–95.CrossRefGoogle Scholar
  3. 3.
    Callihan EB, Gao D, Jindal S, et al. Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer. Breast Cancer Res Treat. 2013;138(2):549–59.CrossRefGoogle Scholar
  4. 4.
    Faupel-Badger JM, Arcaro KF, Balkam JJ, et al. Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop. J Natl Cancer Inst. 2013;105(3):166–74.CrossRefGoogle Scholar
  5. 5.
    Office of the Surgeon General (US); Centers for Disease Control and Prevention (US); Office on Women’s Health (US). The Surgeon General’s Call to Action to Support Breastfeeding. Rockville (MD): Office of the Surgeon General (US); 2011. Rates of Breastfeeding. https://www.ncbi.nlm.nih.gov/books/NBK52681/. Accessed 4 Jan 2019.
  6. 6.
    The Lancet. Breastfeeding: a missed opportunity for global health. Lancet. 2017;390(10094):532.Google Scholar
  7. 7.
    Henry M, Huang LN, Sproule BJ, Cardonick EH. The psychological impact of a cancer diagnosed during pregnancy: determinants of long-term distress. Psychooncology. 2012;21(4):444–50.CrossRefGoogle Scholar
  8. 8.
    International Board of Lactation Consultant Examiners: History. https://iblce.org/about-iblce/history/. Accessed 11 June 2019.
  9. 9.
    Academy of Breastfeeding Medicine: about ABM. https://www.bfmed.org/about. Accessed 11 June 2019.
  10. 10.
    BFAR. Breastfeeding after breast and nipple surgeries. www.bfar.org. Accessed 13 Nov 2018.
  11. 11.
    Gorman JR, Usita PM, Madlensky L, Pierce JP. A qualitative investigation of breast cancer survivors’ experiences with breastfeeding. J Cancer Surviv. 2009;3(3):181–91.CrossRefGoogle Scholar
  12. 12.
    Azim HA, Bellettini G, Gelber S, Peccatori FA. Breast-feeding after breast cancer: if you wish, madam. Breast Cancer Res Treat. 2009;114(1):7–12.CrossRefGoogle Scholar
  13. 13.
    Connell S, Patterson C, Newman B. A qualitative analysis of reproductive issues raised by young Australian women with breast cancer. Health Care Women Int. 2006;27(1):94–110.CrossRefGoogle Scholar
  14. 14.
    Helewa M, Lévesque P, Provencher D, et al. Breast cancer, pregnancy, and breastfeeding. J Obstet Gynaecol Can. 2002;24(2):164–80; quiz 181-4.CrossRefGoogle Scholar
  15. 15.
    Michaels AM, Wanner H. Breastfeeding twins after mastectomy. J Hum Lact. 2013;29(1):20–2.CrossRefGoogle Scholar
  16. 16.
    Chapman T, Pincombe J, Harris M. Antenatal breast expression: a critical review of the literature. Midwifery. 2013;29(3):203–10.CrossRefGoogle Scholar
  17. 17.
    Leal SC, Stuart SR, Carvalho HA. Breast irradiation and lactation: a review. Expert Rev Anticancer Ther. 2013;13(2):159–64.CrossRefGoogle Scholar
  18. 18.
    Schlenz I, Kuzbari R, Gruber H, Holle J. The sensitivity of the nipple-areola complex: an anatomic study. Plast Reconstr Surg. 2000;105(3):905–9.CrossRefGoogle Scholar
  19. 19.
    Karacalar A, Orak I, Aydýn O, Yaln T. Spontaneous recanalization of the divided lactiferous duct in the rat. Ann Plast Surg. 2005;54(2):196–200.CrossRefGoogle Scholar
  20. 20.
    Schnitt SJ, Connolly JL, Harris JR, Cohen RB. Radiation-induced changes in the breast. Hum Pathol. 1984;15(6):545–50.CrossRefGoogle Scholar
  21. 21.
    Moore GH, Schiller JE, Moore GK. Radiation-induced histopathologic changes of the breast: the effects of time. Am J Surg Pathol. 2004;28(1):47–53.CrossRefGoogle Scholar
  22. 22.
    Green JP. Post-irradiation lactation. Int J Radiat Oncol Biol Phys. 1989;17(1):244.CrossRefGoogle Scholar
  23. 23.
    Guix B, Tello JI, Finestres F, Palma C, Martínez A. Lactation after conservative treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2000;46(2):515–6.CrossRefGoogle Scholar
  24. 24.
    Stopenski S, Aslam A, Zhang X, Cardonick E. After chemotherapy treatment for maternal cancer during pregnancy: is breastfeeding possible? Breastfeed Med. 2017;12:91–7.CrossRefGoogle Scholar
  25. 25.
    The InfantRisk Center. Texas Tech University Health Sciences Center. 2019. https://www.infantrisk.com/. Accessed 4 Jan 2019.
  26. 26.
    Shaaban MM. Suppression of lactation by an antiestrogen, tamoxifen. Eur J Obstet Gynecol Reprod Biol. 1975;4(5):167–9.CrossRefGoogle Scholar
  27. 27.
    Masala A, Delitala G, Lo Dico G, Stoppelli I, Alagna S, Devilla L. Inhibition of lactation and inhibition of prolactin release after mechanical breast stimulation in puerperal women given tamoxifen or placebo. Br J Obstet Gynaecol. 1978;85(2):134–7.CrossRefGoogle Scholar
  28. 28.
    Cardoso F, Loibl S, Pagani O, et al. The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. Eur J Cancer. 2012;48(18):3355–77.CrossRefGoogle Scholar
  29. 29.
    Pagani O, Ruggeri M, Manunta S, et al. Pregnancy after breast cancer: are young patients willing to participate in clinical studies? Breast. 2015;24(3):201–7.CrossRefGoogle Scholar
  30. 30.
    Stuebe AM, Horton BJ, Chetwynd E, Watkins S, Grewen K, Meltzer-Brody S. Prevalence and risk factors for early, undesired weaning attributed to lactation dysfunction. J Womens Health (Larchmt). 2014;23(5):404–12.CrossRefGoogle Scholar
  31. 31.
    Eglash A. Treatment of maternal hypergalactia. Breastfeed Med. 2014;9(9):423–5.CrossRefGoogle Scholar
  32. 32.
    Schackmuth EM, Harlow CL, Norton LW. Milk fistula: a complication after core breast biopsy. AJR Am J Roentgenol. 1993;161(5):961–2.CrossRefGoogle Scholar
  33. 33.
    Barker P. Milk fistula: an unusual complication of breast biopsy. J R Coll Surg Edinb. 1988;33(2):106.PubMedGoogle Scholar
  34. 34.
    diFlorio-Alexander RM, Slanetz PJ, Moy L, et al. ACR appropriateness criteria. J Am Coll Radiol. 2018;15(11S):S263–75.CrossRefGoogle Scholar
  35. 35.
    Hendrick RE. Radiation doses and cancer risks from breast imaging studies. Radiology. 2010;257(1):246–53.CrossRefGoogle Scholar
  36. 36.
    Vashi R, Hooley R, Butler R, Geisel J, Philpotts L. Breast imaging of the pregnant and lactating patient: imaging modalities and pregnancy-associated breast cancer. AJR Am J Roentgenol. 2013;200(2):321–8.CrossRefGoogle Scholar
  37. 37.
    Sabate JM, Clotet M, Torrubia S, et al. Radiologic evaluation of breast disorders related to pregnancy and lactation. Radiographics. 2007;27 Suppl 1:S101–24.CrossRefGoogle Scholar
  38. 38.
    Vashi R, Hooley R, Butler R, Geisel J, Philpotts L. Breast imaging of the pregnant and lactating patient: physiologic changes and common benign entities. AJR Am J Roentgenol. 2013;200(2):329–36.CrossRefGoogle Scholar
  39. 39.
    Espinosa LA, Daniel BL, Vidarsson L, Zakhour M, Ikeda DM, Herfkens RJ. The lactating breast: contrast-enhanced MR imaging of normal tissue and cancer. Radiology. 2005;237(2):429-36.CrossRefGoogle Scholar
  40. 40.
    Oh SW, Lim HS, Moon SM, et al. MR imaging characteristics of breast cancer diagnosed during lactation. Br J Radiol. 2017;90(1078):20170203.CrossRefGoogle Scholar
  41. 41.
    Leide-Svegborn S, Ahlgren L, Johansson L, Mattsson S. Excretion of radionuclides in human breast milk after nuclear medicine examinations. Biokinetic and dosimetric data and recommendations on breastfeeding interruption. Eur J Nucl Med Mol Imaging. 2016;43(5):808–21.CrossRefGoogle Scholar
  42. 42.
    Mattsson S, Johansson L, Leide Svegborn S, et al. Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances. Annex D. Recommendations on breast-feeding interruptions. Ann ICRP. 2015;44(2 Suppl):319–21.Google Scholar
  43. 43.
    ACR Committee on Drugs and Contrast Media. American College of Radiology Manual on Contrast Media, Version 10.3. 11th edn. p 99–100. https://www.acr.org/-/media/ACR/Files/Clinical-Resources/Contrast_Media.pdf. Accessed 4 Jan 2019.
  44. 44.
    Pistilli B, Bellettini G, Giovannetti E, et al. Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: how should we counsel cancer patients about breastfeeding? Cancer Treat Rev. 2013;39(3):207–11.CrossRefGoogle Scholar
  45. 45.
    Griffin SJ, Milla M, Baker TE, Liu T, Wang H, Hale TW. Transfer of carboplatin and paclitaxel into breast milk. J Hum Lact. 2012;28(4):457–9.CrossRefGoogle Scholar
  46. 46.
    Amato D, Niblett JS. Neutropenia from cyclophosphamide in breast milk. Med J Aust. 1977;1(11):383–4.PubMedGoogle Scholar
  47. 47.
    Durodola JI. Administration of cyclophosphamide during late pregnancy and early lactation: a case report. J Natl Med Assoc. 1979;71(2):165–6.PubMedPubMedCentralGoogle Scholar
  48. 48.
    Drugs and Lactation Database (LactMed). U.S. National Library of Medicine, National Institute of Health, Health & Human Services. https://toxnet.nlm.nih.gov/newtoxnet/lactmed.htm. Accessed 4 Jan 2019.
  49. 49.
    Anderson PO. Cancer Chemotherapy. Breastfeed Med. 2016;11:164–5.CrossRefGoogle Scholar
  50. 50.
    Urbaniak C, McMillan A, Angelini M, et al. Effect of chemotherapy on the microbiota and metabolome of human milk, a case report. Microbiome. 2014;2:24.CrossRefGoogle Scholar
  51. 51.
    Hill DR, Newburg DS. Clinical applications of bioactive milk components. Nutr Rev. 2015;73(7):463–76.CrossRefGoogle Scholar
  52. 52.
    Dominici LS, Kuerer HM, Babiera G, et al. Wound complications from surgery in pregnancy-associated breast cancer (PABC). Breast Dis. 2010;31(1):1–5.CrossRefGoogle Scholar
  53. 53.
    Jindal S, Gao D, Bell P, et al. Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodeling. Breast Cancer Res. 2014;16(2):R31.CrossRefGoogle Scholar
  54. 54.
    Allegaert K, Miserez M, Lerut T, Naulaers G, Vanhole C, Devlieger H. Methemoglobinemia and hemolysis after enteral administration of methylene blue in a preterm infant: relevance for pediatric surgeons. J Pediatr Surg. 2004;39(1):E35–7.CrossRefGoogle Scholar
  55. 55.
    Sills MR, Zinkham WH. Methylene blue-induced Heinz body hemolytic anemia. Arch Pediatr Adolesc Med. 1994;148(3):306–10.CrossRefGoogle Scholar
  56. 56.
    Albert M, Lessin MS, Gilchrist BF. Methylene blue: dangerous dye for neonates. J Pediatr Surg. 2003;38(8):1244–5.CrossRefGoogle Scholar
  57. 57.
    Giammarile F, Alazraki N, Aarsvold JN, et al. The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer. Eur J Nucl Med Mol Imaging. 2013;40(12):1932–47.CrossRefGoogle Scholar
  58. 58.
    National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: genetic/familial high-risk assessment: breast and ovarian, Version 2.2019. https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf. Accessed 19 Nov 2018.
  59. 59.
    Carbine NE, Lostumbo L, Wallace J, Ko H. Risk-reducing mastectomy for the prevention of primary breast cancer. Cochrane Database Syst Rev. 2018;4:CD002748.PubMedGoogle Scholar
  60. 60.
    Eck DL, Perdikis G, Rawal B, Bagaria S, McLaughlin SA. Incremental risk associated with contralateral prophylactic mastectomy and the effect on adjuvant therapy. Ann Surg Oncol. 2014;21(10):3297–303.CrossRefGoogle Scholar
  61. 61.
    Silva AK, Lapin B, Yao KA, Song DH, Sisco M. The effect of contralateral prophylactic mastectomy on perioperative complications in women undergoing immediate breast reconstruction: a NSQIP analysis. Ann Surg Oncol. 2015;22(11):3474–80.CrossRefGoogle Scholar
  62. 62.
    Rieth EF, Barnett KM, Simon JA. Implementation and organization of a perioperative lactation program: a descriptive study. Breastfeed Med. 2018;13(2):97–105.CrossRefGoogle Scholar
  63. 63.
    Reece-Stremtan S, Campos M, Kokajko L, Medicine AoB. ABM clinical protocol #15: analgesia and anesthesia for the breastfeeding mother, Revised 2017. Breastfeed Med. 2017;12(9):500–6.CrossRefGoogle Scholar
  64. 64.
    Shachar SS, Gallagher K, McGuire K, et al. Multidisciplinary management of breast cancer during pregnancy. Oncologist. 2017;22(3):324–34.CrossRefGoogle Scholar
  65. 65.
    Murphy J, Sherman ME, Browne EP, et al. Potential of breastmilk analysis to inform early events in breast carcinogenesis: rationale and considerations. Breast Cancer Res Treat. 2016;157(1):13–22.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  1. 1.Department of Surgery, Brody School of MedicineEast Carolina UniversityGreenvilleUSA
  2. 2.Breast Surgical OncologyPresbyterian Healthcare Services – MD Anderson Cancer NetworkAlbuquerqueUSA

Personalised recommendations